Assistant Professor, Pediatrics, Baylor College of Medicine
Pediatric Hematology & Oncology
Dr. Jack M. Su, MD
|
|
Give Review
Jack is an expert in the field of Pediatric Hematology & Oncology. He attended University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine Dr. Jack M. Su is also a published MD. He has 26 publication published. The most recent publication is: Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.
Publications
- Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.
- A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric Brain tumor consortium study.
- Folic acid supplementation and dietary folate intake, and risk of preeclampsia.
- Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma.
- p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through Immune modulation.
- A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†.
- A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children.
- Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
- Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.
- Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
- Long-term outcome of centrally located low-grade glioma in children.
- A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.
- Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of Medulloblastoma.
- Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report.
- A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves Cancer stem cells in vivo.
- Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for Medulloblastoma.
- Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of Medulloblastoma and glioma.
- Valproic acid induces growth arrest, apoptosis, and senescence in Medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, a...
- αNAC inhibition of the FADD-JNK axis plays anti-apoptotic role in multiple Cancer cells.
- The interaction between mesenchymal stem cells and steroids during inflammation.
- A single intravenous injection of oncolytic picornavirus SVV-001 eliminates Medulloblastomas in primary tumor-based orthotopic xenograft mouse models.
- Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates.
- Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases.
- Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic Medulloblastoma xenografts.
- Comparison of ethanol versus formalin fixation on preservation of histology and RNA in laser capture microdissected Brain tissues.
Schools
University of California At San Francisco
University Calif
Tex Chldn39s HospBaylor College Med
Conditions Treated
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Immune Thrombocytopenic Purpura (ITP)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- CHAMPVA
- Great West Healthcare-Cigna PPO
- LocalPlus
- Commercial Insurance Company
- Emblem Health
- Preferred PPO
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Baylor College of Medicine -
UCSF -
University of California San Francisco School of Medicine
Hospital
-
Texas Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Zoann Dreyer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nidale G. Tarek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter E. Zage, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Christopher C. Derenzo
This Doctor is OpenDoctor Recommended.
|